Patterns of survival in patients with recurrent follicular lymphoma: A 20-year study from a single center

Journal of Clinical Oncology

Volumn 13, Issue 1, 1995, Pages 140-147

  Johnson, P W M ^b   Rohatiner, A Z S ^b   Whelan, J S ^b   Price, C G A ^b   Love, S ^b   Lim, J ^b   Matthews, J ^b   Norton, A J ^b   Amess, J A L ^b   Lister, T A ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SURVIVAL TIME; TREATMENT OUTCOME;

AGE FACTORS; ANALYSIS OF VARIANCE; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMAN; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGE; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0028835315     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.1.140     Document Type: Article

References (24)

1. Gall EA, Mallory TB: Malignant lymphoma: A clinico-pathologic survey of 618 cases. Am J Pathol 18:281-429, 1942
2. Rosenberg SA: The low-grade non-Hodgkin's lymphomas: Challenges and opportunities. J Clin Oncol 3:299-310, 1985
3. Gallagher CJ, Gregory WM, Jones AE, et al: Follicular lymphoma: Prognostic factors for response and survival. J Clin Oncol 4:1470-1480, 1986
4. Ersboll J, Schultz HB, Pedersen-Bjergaard J, et al: Follicular low-grade non-Hodgkin's lymphoma: Long-term outcome with or without tumor progression. Eur J Haematol 42:155-163, 1989
5. Portlock CS: Management of the low-grade non-Hodgkin's lymphomas. Semin Oncol 17:51-59, 1990
6. Horning SJ, Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311:1471-1475, 1984
7. Ezdinli Z, Anderson JR, Melvin F, et al: Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma. J Clin Oncol 3:769-775, 1985
8. Young RC, Longo DL, Glatstein E, et al: The treatment of indolent lymphomas: Watchful waiting v. aggressive combined modality treatment. Semin Hematol 25:11-16, 1988
9. Soubeyran P, Eghbali H, Bonichon F, et al: Low-grade follicular lymphomas: Analysis of prognosis in a series of 281 patients. Eur J Cancer 27:1606-1613, 1991
10. Gerard-Marchant R, Hamlin I, Lennert K, et al: Classification of non-Hodgkin's lymphoma. Lancet 2:406-408, 1974
11. Rohatiner AZS, Johnson PWM, Price CGA, et al: Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent low grade B cell lymphoma. J Clin Oncol 12:1177-1184, 1994
12. Peto R, Pike MC, Armitage P: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II Analysis and examples. Br J Cancer 35:1-39, 1977
13. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
14. Gregory W: Adjusting survival curves for imbalances in prognostic factors. Br J Cancer 58:202-204, 1988
15. Paryani SB, Hoppe RT, Cox RS, et al: Analysis of non-Hodgkin's lymphomas with nodular and favourable histologies, stages I and II. Cancer 52:2300-2307, 1983
16. Richards MA, Gregory WM, Hall PA, et al: Management of localized non-Hodgkin's lymphoma: The experience at St Bartholomew's Hospital 1972-1985. Hematol Oncol 7:1-18, 1989
17. Bastion Y, Berger F, Bryon PA, et al: Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years. Ann Oncol 2:123-129, 1991 (suppl 2)
18. Leonard RCF, Hayward RL, Prescott RJ, et al: The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma. Ann Oncol 2:655-662, 1991
19. Freedman AS, Ritz J, Neuberg D, et al: Autologous bone marrow transplantation in 69 patients with a history of low grade B-cell non-Hodgkin's lymphoma. Blood 77:2524-2529, 1991
20. Price CGA, Rohatiner AZS, Steward WP, et al: Interferon-a2b in the treatment of follicular lymphoma: Preliminary results of a trial in progress. Ann Oncol 2:141-145, 1991 (suppl 2)
21. Hagenbeek A, Carde P, Somers R, et al: Maintenance of remission with human recombinant alpha-2 Interferon (Roferon-A) in patients with stages III and IV low grade malignant non-Hodgkin's lymphoma. Results from a prospective, randomized phase III clinical trial in 331 patients. Blood 80:74a, 1992 (suppl 1, abstr)
22. Meeker TC, Lowder J, Maloney DG, et al: A clinical trial of anti-idiotype therapy for B-cell malignancy. Blood 65:1349-1363, 1985
23. Kwak LW, Campbell MJ, Czerwinski DK, et al: Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 327:1209-1215, 1992
24. Reed JC, Stein C, Subasinghe C, et al: Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res 50:6565-6570, 1990